Valproate and Levocarnitine in Children With Spinal Muscular Atrophy
Randomized Placebo Controlled Trial of Valproate and Levocarnitine in Children With Spinal Muscular Atrophy Aged 2-15 Years Randomized Placebo Controlled Trial of Valproate and Levocarnitinein Children With Spinal Muscular A ...
Phase I/II Trial of Valproic Acid and Carnitine in Infants with Spinal Muscular Atrophy Type I (CARNI-VAL Type I) - CARNI-VAL Type I Phase I/II Trial of Valproic Acid and Carnitinein Infants with Spinal Muscular Atrophy Type I (CARNI ...
Phase I/II Trial of Valproic Acid and Carnitine in Infants with Spinal Muscular Atrophy Type I (CARNI-VAL Type I) - CARNI-VAL Type I Phase I/II Trial of Valproic Acid and Carnitinein Infants with Spinal Muscular Atrophy Type I (CARNI ...
Spinal Muscular Atrophy Type I in infants MedDRA version: 9.1;Level: LLT;Classification code 10051203;Term: Spinal muscular atrophy congenital Spinal Muscular Atrophy Type I in infants MedDRA version: 9.1;Level: LLT;Classification code 1005120 ...
CARNIVAL Type I: Valproic Acid and Carnitine in Infants With Spinal Muscular Atrophy (SMA) Type I
Phase I/II Trial of Valproic Acid and Carnitine in Infants With Spinal Muscular Atrophy Type I (CARNI-VAL Type I) Phase I/II Trial of Valproic Acid and Carnitinein Infants With Spinal Muscular Atrophy Type I (CARNI ...
Valproic Acid and Carnitine in Patients With Spinal Muscular Atrophy
Multi-center Phase II Trial of Valproic Acid and Carnitine in Patients With Spinal Muscular Atrophy (SMA CARNI-VAL Trial) Multi-center Phase II Trial of Valproic Acid and Carnitinein Patients With Spinal Muscular Atrophy ( ...